TY - JOUR
T1 - Breast cancer risk factors and survival by tumor subtype
T2 - pooled analyses from the Breast Cancer Association Consortium
AU - Morra, Anna
AU - Jung, Audrey Y
AU - Behrens, Sabine
AU - Keeman, Renske
AU - Ahearn, Thomas U
AU - Anton-Cluver, Hoda
AU - Arndt, Volker
AU - Augustinsson, Annelie
AU - Auvinen, Päivi K
AU - Beane Freeman, Laura E
AU - Becher, Heiko
AU - Beckmann, Matthias W
AU - Bloomqvist, Carl
AU - Bojesen, Stig E
AU - Bolla, Manjeet K
AU - Brenner, Hermann
AU - Briceno, Ignacio
AU - Brucker, Sara Y
AU - Camp, Nicola J
AU - Campa, Daniele
AU - Canzian, Federico
AU - Castelao, Jose E
AU - Chanock, Stephen J
AU - Choi, Ji-Yeob
AU - Clarke, Christine L
AU - Couch, Fergus J
AU - Cox, Angela
AU - Cross, Simon S
AU - Czene, Kamila
AU - Dӧrk, Thilo
AU - Dunning, Alison M
AU - Dwek, Miriam
AU - Easton, Douglas F
AU - Eccles, Diana M
AU - Egan, Kathleen M
AU - Evans, D Gareth
AU - Fasching, Peter A
AU - Flyger, Henrik
AU - Gago-Dominguez, Manuela
AU - Gapstur, Susan M
AU - Garcia-Saenz, Jose A
AU - Gaudet, Mia M
AU - Giles, Graham G
AU - Grip, Mervi
AU - Guénel, Pascal
AU - Haiman, Christopher A
AU - Håkansson, Niclas
AU - Hall, Per
AU - Hamann, Ute
AU - Olsson, Håkan
AU - Breast Cancer Association Consortium
N1 - Copyright ©2021, American Association for Cancer Research.
PY - 2021
Y1 - 2021
N2 - BACKGROUND: It is not known if modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype.METHODS: We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer-specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer-specific mortality overall, by estrogen receptor (ER) status, and by intrinsic-like subtype.RESULTS: There was no evidence of heterogeneous associations between risk factors and mortality by subtype (adjusted p>0.30). The strongest associations were between all-cause mortality and BMI {greater than or equal to}30 vs 18.5-25 kg/m2 (HR (95%CI): 1.19 (1.06,1.34)); current vs never smoking (1.37 (1.27,1.47)), high vs low physical activity (0.43 (0.21,0.86)), age {greater than or equal to}30 years vs <20 years at first pregnancy (0.79 (0.72,0.86)); >0 to <5 years vs {greater than or equal to}10 years since last full term birth (1.31 (1.11,1.55)); ever vs never use of oral contraceptives (0.91 (0.87,0.96)); ever vs never use of menopausal hormone therapy, including current estrogen-progestin therapy (0.61 (0.54,0.69)). Similar associations with breast cancer mortality were weaker; e.g. 1.11 (1.02,1.21) for current vs never smoking.CONCLUSIONS: We confirm associations between modifiable lifestyle factors and 10-year all-cause mortality. There was no strong evidence that associations differed by ER status or intrinsic-like subtype.IMPACT: Given the large dataset and lack of evidence that associations between modifiable risk factors and 10-year mortality differed by subtype, these associations could be cautiously used in prognostication models to inform patient-centered care.
AB - BACKGROUND: It is not known if modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype.METHODS: We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer-specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer-specific mortality overall, by estrogen receptor (ER) status, and by intrinsic-like subtype.RESULTS: There was no evidence of heterogeneous associations between risk factors and mortality by subtype (adjusted p>0.30). The strongest associations were between all-cause mortality and BMI {greater than or equal to}30 vs 18.5-25 kg/m2 (HR (95%CI): 1.19 (1.06,1.34)); current vs never smoking (1.37 (1.27,1.47)), high vs low physical activity (0.43 (0.21,0.86)), age {greater than or equal to}30 years vs <20 years at first pregnancy (0.79 (0.72,0.86)); >0 to <5 years vs {greater than or equal to}10 years since last full term birth (1.31 (1.11,1.55)); ever vs never use of oral contraceptives (0.91 (0.87,0.96)); ever vs never use of menopausal hormone therapy, including current estrogen-progestin therapy (0.61 (0.54,0.69)). Similar associations with breast cancer mortality were weaker; e.g. 1.11 (1.02,1.21) for current vs never smoking.CONCLUSIONS: We confirm associations between modifiable lifestyle factors and 10-year all-cause mortality. There was no strong evidence that associations differed by ER status or intrinsic-like subtype.IMPACT: Given the large dataset and lack of evidence that associations between modifiable risk factors and 10-year mortality differed by subtype, these associations could be cautiously used in prognostication models to inform patient-centered care.
U2 - 10.1158/1055-9965.EPI-20-0924
DO - 10.1158/1055-9965.EPI-20-0924
M3 - Article
C2 - 33500318
SN - 1538-7755
VL - 30
SP - 623
EP - 642
JO - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
JF - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
IS - 4
ER -